Opthea - Stock Price History | OPT

Historical daily share price chart and data for Opthea since 2021 adjusted for splits. The latest closing stock price for Opthea as of September 27, 2021 is 7.79.
  • The all-time high Opthea stock closing price was 13.50 on November 23, 2020.
  • The Opthea 52-week high stock price is 16.23, which is 108.3% above the current share price.
  • The Opthea 52-week low stock price is 6.41, which is 17.7% below the current share price.
  • The average Opthea stock price for the last 52 weeks is 9.89.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Opthea Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 12.6200 12.3000 13.5000 11.1100 11.2150 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.342B $0.000B
Opthea Limited is a biotechnology company. It develops and commercializes therapies primarily for eye disease principally in Australia. Opthea Limited is based in South Yarra, Australia.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29